• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重新筛查项目中使用探路者系统以减少宫颈细胞学涂片异常病例的漏诊。

Using the Pathfinder system to reduce missed abnormal cervical cytologic smear cases in a rescreening program.

作者信息

Berger B M

机构信息

Department of Pathology and Laboratory Medicine, Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA.

出版信息

Acta Cytol. 1997 Jan-Feb;41(1):173-81. doi: 10.1159/000332320.

DOI:10.1159/000332320
PMID:9022741
Abstract

OBJECTIVE

To evaluate the effect of Pathfinder (CompuCyte Corp., Cambridge, Massachusetts, U.S.A.), a process control instrument for microscopes used by cytotechnologists to monitor the mechanical aspects of their screening process, on the false negative cervical cytologic smear rate as detected in daily quality assurance rescreening.

STUDY DESIGN

Pathfinder was put into routine use in a large cytology laboratory. After cytotechnologists were trained in its use, they monitored their time spent screening each slide, the area (percent) of the slide screened and the average percentage of overlap of fields of view. The number of abnormal cases missed in screening before and after the introduction of Pathfinder was determined by rescreening a random 10% of the "negative" cases. The evaluation took place over a nine-month period.

RESULTS

A decrease in the number of missed abnormal cases was identified. The false negative rate for atypical cells of undetermined significance (ASCUS) fell from 37/2,336 (1.6%) to 12/1,772 (0.7%), for a 56% decrease. The change in the number of squamous intraepithelial lesion cases, even over a nine-month period, was too small for comment.

CONCLUSION

The effect of the continuous feedback and process standardization provided by the Pathfinder system was a decrease in the number of abnormal cases missed. This was due primarily to a marked decrease in the number of ASCUS cases missed. The Pathfinder provides a number of innovative management tools to ensure consistent high quality screening.

摘要

目的

评估Pathfinder(美国马萨诸塞州剑桥市CompuCyte公司)这一由细胞技术人员用于显微镜检查过程控制的仪器,对日常质量保证复查中检测到的宫颈细胞学涂片假阴性率的影响。

研究设计

Pathfinder在一家大型细胞学实验室投入日常使用。细胞技术人员接受该仪器使用培训后,他们监测每张玻片的筛查时间、玻片筛查面积(百分比)以及视野平均重叠百分比。通过对随机抽取的10%“阴性”病例进行复查,确定引入Pathfinder前后筛查中漏诊的异常病例数。评估为期九个月。

结果

发现漏诊的异常病例数有所减少。意义不明确的非典型细胞(ASCUS)的假阴性率从2336例中的37例(1.6%)降至1772例中的12例(0.7%),下降了56%。鳞状上皮内病变病例数的变化,即使在九个月期间,也因变化过小而无法评论。

结论

Pathfinder系统提供的持续反馈和流程标准化的作用是减少了漏诊的异常病例数。这主要归因于ASCUS漏诊病例数的显著减少。Pathfinder提供了许多创新的管理工具,以确保始终如一地进行高质量筛查。

相似文献

1
Using the Pathfinder system to reduce missed abnormal cervical cytologic smear cases in a rescreening program.在重新筛查项目中使用探路者系统以减少宫颈细胞学涂片异常病例的漏诊。
Acta Cytol. 1997 Jan-Feb;41(1):173-81. doi: 10.1159/000332320.
2
Impact of the Pathfinder in a cytology laboratory.
Acta Cytol. 1997 Jan-Feb;41(1):166-72. doi: 10.1159/000332319.
3
Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.神经网络辅助分析与对疑似阴性宫颈细胞学涂片进行显微镜复查:一项比较研究
Acta Cytol. 1998 Jan-Feb;42(1):227-32. doi: 10.1159/000331551.
4
A feasibility study of the AutoPap system location-guided screening.自动巴氏涂片系统定位引导筛查的可行性研究。
Acta Cytol. 1998 Jan-Feb;42(1):221-6. doi: 10.1159/000331550.
5
Statistical quality assurance in cytology. Use of the Pathfinder to continuously assess screener process control in real time.细胞学中的统计质量保证。使用Pathfinder实时持续评估筛查人员的过程控制。
Acta Cytol. 1996 Jan-Feb;40(1):97-106. doi: 10.1159/000333590.
6
Using a CompuCyte Pathfinder to evaluate cytotechnology student diagnostic performance.使用CompuCyte Pathfinder评估细胞技术专业学生的诊断表现。
Acta Cytol. 1997 Jan-Feb;41(1):160-5. doi: 10.1159/000332318.
7
False negative rate of cervical cytologic smear screening as determined by rapid rescreening.
Acta Cytol. 1999 May-Jun;43(3):344-50. doi: 10.1159/000331079.
8
Screening parameters for ThinPrep and conventional gynecologic cytology via automated monitoring.通过自动监测对ThinPrep和传统妇科细胞学的筛查参数。
Acta Cytol. 2000 Jul-Aug;44(4):618-24. doi: 10.1159/000328537.
9
The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.用于宫颈涂片质量控制再筛查的AutoPap 300质量控制(QC)系统多中心临床试验:I. 一项前瞻性预期用途研究。
Cancer. 1997 Dec 25;81(6):337-42. doi: 10.1002/(sici)1097-0142(19971225)81:6<337::aid-cncr7>3.0.co;2-i.
10
The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.用于宫颈涂片质量控制再筛查的AutoPap 300质量控制系统多中心临床试验:II. 前瞻性和存档敏感性研究。
Cancer. 1997 Dec 25;81(6):343-7. doi: 10.1002/(sici)1097-0142(19971225)81:6<343::aid-cncr8>3.0.co;2-m.